Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa

BMC Pregnancy and Childbirth

Volumn 16, Issue 1, 2016, Pages

  Moodley, Theron ^a   Moodley, Dhayendre ^a   Sebitloane, Motshedisi ^a   Maharaj, Niren ^a   Sartorius, Benn ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE; NEVIRAPINE; STAVUDINE; STAVUDINE, LAMIVUDINE, NEVIRAPINE DRUG COMBINATION; ZIDOVUDINE;

ADOLESCENT; ADULT; EPIDEMIOLOGY; FEMALE; HIV INFECTIONS; HUMAN; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL CARE; PREVENTION AND CONTROL; SOUTH AFRICA; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VERTICAL TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; EFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE DRUG COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL CARE; SOUTH AFRICA; STAVUDINE; YOUNG ADULT; ZIDOVUDINE;

EID: 84957689503     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-016-0821-3     Document Type: Article

References (25)

1. World Health Organisation. Antiretroviral drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards Universal Access: Recommendations for a Public Health Apprach. Geneva: WHO Department of HIV/AIDS; 2006.
2. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO Department of HIV/AIDS; 2010. Revision.
3. Moodley P, Parboosing R, Moodley D. Reduction in Perinatal HIV infections in KwaZulu-Natal, South Africa in the era of more effective PMTCT Interventions (2004-2012). JAIDS. 2013;63(3):410-5. doi: 10.1097/QAI.0b013e3182926931.
4. Stringer JSA, Stinson K, Tih PM, Giganti MJ, Ekouevi DK, Creek T, et al. Measuring coverage in MNCH: population HIV-free survival among children under Two years of Age in four African countries. PLoS Med. 2013;10(5), e1001424. doi: 10.1371/journal.pmed.1001424.
5. Joint United Nations Programme on HIV/AIDS (UNAIDS). Together we will end AIDS. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS). 2012. Available at http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/jc2296_unaids_togetherreport_2012_en.pdf.
6. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO Department of HIV/AIDS; 2013.
7. United Nations. New York. Millenium Development Goals Report. 2015. www.un.org/en/development/desa/publications/mdg-report-2015.html. Accessed 07 December 2015.
8. Bryce J, Black RE, Victora CG. Millennium development goals 4 and 5: progress and challenges. BMC Med. 2013 Oct 16;11:225. doi: 10.1186/1741-7015-11-225.
9. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post -2015 priorities: an updated systematic analysis. Lancet Jan. 2015;385:430-40.
10. Lambert JS, Watts DH, Mofenson L, Stiehm ER, Harris DR, Bethel J, et al. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS. 2000 Jul 7;14(10):1389-99.
11. Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med. 2002;346(24):1863.
12. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis. 2006;193:1195-201.
13. Turner AN, Tabbah S, Mwapasa V, Rogerson SJ, Meshnick SR, Ackerman IV W, et al. Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study. J AIDS. 2013;64(4):392-9.
14. Habib NA, Daltveit AK, Bergsjø P, Shao J, Oneko O, Lie RT. Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study. BJOG. 2008 Apr, 115(5):616-24. doi: 10.1111/j.1471-0528.2008.01672.x.
15. Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis. 2012;206(11):1695-705.
16. Fowler MG, Qin M, Fiscus SA, for the Promise Study Team. PROMISE: Efficacy and Safety of Two Strategies to Prevent Perinatal HIV Transmission. Washington DC: Paper presented at: 22nd Conference on Retroviruses and Opportunistic Infections (CROI 2015); 2015.
17. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162-72. doi: 10.1016/S0140-6736(12)60820-4.
18. van der Merwe K, Chersich M, Black V, Technau K, Rees H, Coovadia A. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc. 2011;14:42.
19. Ravizza M, Martinelli P, Bucceri A, Fiore S, Alberico S, Tamburrini E, et al. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis. 2007;195(6):913-4. author reply 6-7.
20. Bussmann H, Wester CW, Wester CN, Lekoko B, Okezie O, Thomas AM, et al. Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana. J Acquir Immune Defic Syndr. 2007;45(3):269-73.
21. Ekouevi DK, Coffie PA, Ouattara E, Moh R, Amani-Bosse C, Messou E, et al. Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2011;56(2):183-7.
22. Matambo J, Moodley D, Moodley J. HIV Seroprevalence and Rapid testing in Unbooked Pregnant African Women. Int J Obstet Gynaecol. 1999;66:289-90.
23. Lindsay MK, Feng TI, Peterson HB, Slade BA, Willis S, Klein L. Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstet Gynecol. 1991;77(4):599-603.
24. Fawcus SR, Crowther CA, Van Baelen P, Marumahoko J. Booked and unbooked mothers delivering at Harare Maternity Hospital, Zimbabwe: a comparison of maternal characteristics and foetal outcome. Cent Afr J Med. 1992;38(10):402-8.
25. Osungbade KO, Ayinde OO. Birth outcomes among booked and unbooked women at a secondary health facility in southwest Nigeria: implications for strengthening perinatal health services. J Child Health Care. 2011 Dec;15(4):320-8. doi: 10.1177/1367493511406569. Epub 2011 Aug 9.